Investor Presentaiton
Performance: currency
2022 currency sales exposure¹
US $
Euro €
48%
17%
Japanese \
7%
Other²
28%
2023 adj. operating profit
US $: 10 cents movement in the average exchange rate for full
year impacts adj. operating profit by approx. +/- 8.0%
Euro €: 10 cents movement in the average exchange rate for full
year impacts adj. operating profit by approx. +/- 0.5%
Japanese ¥: 10 Yen movement in the average exchange rate
for full year impacts adj. operating profit by approx. +/- 1.0%
1. Based on 2022 GSK continuing operations, including COVID-19 solutions
2. The other currencies that each represent more than 1% of GSK sales include Australian Dollar, Brazilian Real, Canadian Dollar, Chinese Yuan and Indian Rupee. In total, they accounted for 9% of GSK revenues in 2022. If exchange rates were to
hold at the closing rates on 27 January 2023 ($1.24/£1, €1.14/£1 and Yen 161/£1) for the rest of 2023, the estimated impact on 2023 Sterling turnover growth for GSK would be stable and if exchange gains or losses were recognised at the same level as in
2022, the estimated impact on 2023 Sterling Adjusted Operating Profit growth for GSK would also be stable.
GSK
36View entire presentation